Activity value 80south korea Buyer&Supplier,Last transaction date:
2026-05-14
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for chong kum dang pharmaceutical corp. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 13 transactions, with a transaction quantity of 92981.2 and a transaction weight of 1178.
Product description
DRUGS AND MEDICINE FOR KIDNEY DIALYSIS CIPOL-N SOFT CAPSULE 25MG (CYCLOSPORINE MICROEMULSION) BATCH NO KG005 QTY 10000.BOXES
Expand
Trade date
2025/12/08
B/L No.
——
Suppliers
chong kum dang pharmaceutical corp.
Buyers
hoffman human health pakistan
chong kum dang pharmaceutical corp. is south korea Buyer&Supplier,
and primarily engages in the import and export business of products such as seal oil capsule,box,drug.
According to the 52wmb.com global trade database, as of 2026-05-14, the company has completed 1400 international trades,
with its main trading regions covering vietnam,pakistan,indonesia etc.
The core products include HS21069072,HS30049099,HS30042099000 etc,
often transported via incheon kr,port incheon intl apt seoul, port incheon intl apt seo kr etc,
and its main trading partners are aster life sciences,binh viet duc co.ltd.,dhg pharmaceutical joint stock.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on chong kum dang pharmaceutical corp. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.